Novel substituted 4-(Arylethynyl)-Pyrrolo[2,3-d]pyrimidines negative allosteric modulators (NAMs) of the metabotropic glutamate receptor subtype 5 (mGlu5) Treat depressive disorder in mice-Reference-Cited by-同舟云学术

Novel substituted 4-(Arylethynyl)-Pyrrolo[2,3-d]pyrimidines negative allosteric modulators (NAMs) of the metabotropic glutamate receptor subtype 5 (mGlu5) Treat depressive disorder in mice

Published:2023-12 Issue: Volume:261 Page:115855
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Du Yonglei,Gao Feng,Sun Hongwei,Wu Chenglin,Zhu Guoqi,Zhu Manzhou^ORCID

Funder

NSFC

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference55 articles.

1. Cost and outcome of behavioural activation versus cognitive behavioural therapy for depression (COBRA): a randomised, controlled, non-inferiority trial;Richards;Lancet,2016

2. Incidence and prevalence of primary care antidepressant prescribing in children and young people in England, 1998-2017: a population-based cohort study;Jack;PLoS Med.,2020

3. Polypharmacology: challenges and opportunities in drug discovery;Anighoro;J. Med. Chem.,2014

4. Non-canonical β-adrenergic activation of ERK at endosomes;Kwon;Nature,2022

5. Discovery of 4-amino-3-arylsulfoquinolines, a novel non-acetylenic chemotype of metabotropic glutamate 5 (mGlu5) receptor negative allosteric modulators;Galambos;Eur. J. Med. Chem.,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. cAMP-PKA signaling pathway and anxiety: Where do we go next?;Cellular Signalling;2024-10

2. Discovery of a Novel ASM Direct Inhibitor with a 1,5-Diphenyl-pyrazole Scaffold and Its Antidepressant Mechanism of Action;Journal of Medicinal Chemistry;2024-06-18

3. Mitochondria in depression: The dysfunction of mitochondrial energy metabolism and quality control systems;CNS Neuroscience & Therapeutics;2024-02